Category: Approval/Launch Region: North America · United States Company: Glenmark Pharmaceuticals Inc Usa

Glenmark Pharma Gets Us Fda Approval For Generic Zytiga Tablets

Glenmark Pharma Gets Us Fda Approval For Generic Zytiga Tablets
Glenmark Pharmaceuticals Inc., Usa (Glenmark) Has Received Final Approval By The United States Food & Drug Administration (Fda) For Abiraterone Acetate Tablets Usp, 500 Mg, The Generic Version Of Zytiga Tablets, 500 Mg, Of Janssen Biotech Inc. According To Iqvia Sales Data For The 12 Month Period Ending March 2022, The Zytiga Tablets, 500 Mg Market Achieved Annual Sales Of Approximately $260.2 Million. Glenmark

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!